FPAS
ABBV icon

Focus Partners Advisor Solutions’s AbbVie ABBV Stock Holding History

Focus Partners Advisor Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.94M Sell
31,909
-18,314
-36% -$4.06M 0.07% 134
2025
Q4 		$11.5M Buy
50,223
+13,993
+39% +$3.19M 0.14% 79
2025
Q3 		$8.2M Buy
36,230
+996
+3% +$203K 0.09% 117
2025
Q2 		$6.54M Buy
35,234
+962
+3% +$179K 0.09% 114
2025
Q1 		$7.18M Sell
34,272
-3,124
-8% -$607K 0.11% 99
2024
Q4 		$6.65M Buy
37,396
+3,471
+10% +$638K 0.11% 97
2024
Q3 		$6.7M Buy
33,925
+3,661
+12% +$683K 0.14% 79
2024
Q2 		$5.19M Sell
30,264
-1,942
-6% -$322K 0.14% 82
2024
Q1 		$5.86M Buy
32,206
+22,854
+244% +$3.94M 0.17% 71
2023
Q4 		$1.45M Sell
9,352
-13,148
-58% -$1.92M 0.07% 129
2023
Q3 		$3.35M Buy
22,500
+13,783
+158% +$2.02M 0.16% 65
2023
Q2 		$1.17M Buy
8,717
+971
+13% +$142K 0.07% 120
2023
Q1 		$1.23M Buy
7,746
+3,117
+67% +$477K 0.08% 107
2022
Q4 		$748K Sell
4,629
-14,305
-76% -$2.19M 0.06% 152
2022
Q3 		$2.54M Buy
18,934
+13,432
+244% +$1.93M 0.15% 74
2022
Q2 		$843K Sell
5,502
-266
-5% -$40.6K 0.07% 131
2022
Q1 		$934K Sell
5,768
-1,209
-17% -$176K 0.09% 113
2021
Q4 		$946K Buy
+6,977
New +$824K 0.2% 38

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Focus Partners Advisor Solutions's ABBV Position: Q1 2026 in Review

Focus Partners Advisor Solutions reduced its AbbVie (ABBV) stake by 36% in Q1 2026, selling an estimated $4.06M and leaving 31,909 shares worth $6.94M. The position accounts for 0.07% of the portfolio, ranked #134.

Focus Partners Advisor Solutions first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $11.5M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Focus Partners Advisor Solutions held 31,909 shares of AbbVie worth $6.94M as of Q1 2026.
  • Focus Partners Advisor Solutions sold 18,314 AbbVie shares in Q1 2026, an estimated $4.06M.
  • AbbVie made up 0.07% of Focus Partners Advisor Solutions's portfolio in Q1 2026, its #134 holding.
  • Focus Partners Advisor Solutions first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Focus Partners Advisor Solutions's AbbVie position peaked at $11.5M in Q4 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.